Additionally, irisin treatment shows therapeutic potential for cognitive impairment and synaptic plasticity by modulating neuroinflammation, astrocyte activation, and the expression of P38, STAT3, and NFκB signaling molecules in the rodent diabetic brain [253]. The gene discussed is FNDC5; the disease is Cognitive impairment.